@Poorsaver - As far as I know nobody has done any sort of trial with that stuff with respect to Covid. There are some anecdotal reports with regard to cancer, but again "case reports" do not become "data" no matter how many of them you have.

There IS a plausible mechanism of action with regard to viral replication, but as far as I know nobody has run a trial on it. And unfortunately a "trial of one" is not a trial. It's an interesting anecdote but nothing more, and frankly, given that we have an apparently highly-active agent that works both early AND late, with no reason not to use it, I'd say if we're going to trial this we should do it AGAINST Ivermectin as the control along with placebo.

If you're going to try to find agents then put them against what we already have reason to believe works so we can quantify the results.

----------